Showing 48 results
September 2021
-
Media Release
Novartis receives approval in Singapore for LEQVIO® (inclisiran), an innovative medication that changes the treatment paradigm for patients with high cholesterol
Leqvio® (inclisiran) is an innovative medicine that can change how low-density lipoprotein cholesterol (LDL-C) or commonly known as bad cholesterol is treated.1, 2 Cardiovascular disease (CVD) is… -
Story Discovery
Remote Patient Monitoring: The Unstoppable Wave of New Care Models – The Records
-
In The News
Singapore approves an innovative medication for patients with high cholesterol
Leqvio® (inclisiran) is an innovative medicine that can change how low-density lipoprotein cholesterol (LDL-C) or commonly known as bad cholesterol is treated. -
In The News
Cell therapy for relapsed cancer patients
Singapore has successfully treated its first patient using what is known as chimeric antigen receptor T-cell, or CAR-T therapy.
July 2021
-
In The News
Factories: Making the Future
Ever wondered what it's like inside some of Singapore's factories? This special feature documentary looks at cutting-edge products designed and manufactured in the city-state that will impact the way… -
In The News
Multinational pharmaceutical companies partner with local businesses to help economic recovery
